How big is Shattuck Labs, Inc.?

As of Jun 18, Shattuck Labs, Inc. has a market capitalization of 46.58 million and reported net sales of 4.61 million with a net profit of -70.61 million over the last four quarters.

Market Cap: As of Jun 18, Shattuck Labs, Inc. has a market capitalization of 46.58 million, categorized as a Micro Cap.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Shattuck Labs, Inc. reported net sales of 4.61 million and a net profit of -70.61 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 79.63 million and total assets of 92.25 million.

What does Shattuck Labs, Inc. do?

Shattuck Labs, Inc. is a clinical-stage biotechnology company focused on developing dual-sided fusion proteins. As of March 2025, it has a market cap of $46.58 million and reported a net profit loss of $14 million.

Overview: <BR>Shattuck Labs, Inc. is a clinical-stage biotechnology company engaged in the development of dual-sided fusion proteins within the Pharmaceuticals & Biotechnology industry.<BR><BR>Financial Snapshot: <BR>Net Profit: -14 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 46.58 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.89 <BR>Return on Equity: -104.36% <BR>Price to Book: 0.69<BR><BR>Contact Details: <BR>Address: 1018 W. 11Th Street, Suite 100, AUSTIN TX: 78703 <BR>Tel: 1 919 8642700 <BR>Website: https://www.shattucklabs.com/

Should I buy, sell or hold Shattuck Labs, Inc.?

Who are in the management team of Shattuck Labs, Inc.?

As of March 2022, the management team of Shattuck Labs, Inc. includes Executive Chairman and Co-Founder Mr. Josiah Hornblower and Chief Executive Officer, Co-Founder, and Director Mr. Taylor Schreiber.

As of March 2022, the management team of Shattuck Labs, Inc. includes Mr. Josiah Hornblower, who serves as the Executive Chairman of the Board and is a Co-Founder, and Mr. Taylor Schreiber, who is the Chief Executive Officer, Co-Founder, and a Director.

Is Shattuck Labs, Inc. overvalued or undervalued?

As of November 9, 2023, Shattuck Labs, Inc. is considered overvalued and classified as risky due to its poor financial metrics and significant long-term stock volatility, despite a recent strong performance.

As of 9 November 2023, the valuation grade for Shattuck Labs, Inc. has moved from does not qualify to risky. The company appears to be overvalued given its financial metrics, particularly with a Price to Book Value of 0.81, an EV to EBIT of 0.07, and an EV to EBITDA of 0.08, indicating significant losses relative to its enterprise value. In comparison, peers such as Enzo Biochem, Inc. have a more negative EV to EBITDA of -0.1144, while BioXcel Therapeutics, Inc. shows an EV to EBITDA of -3.1146, suggesting that Shattuck Labs is not performing as well as some of its counterparts.<BR><BR>Despite a strong recent performance with a 1-month stock return of 118.63% compared to the S&P 500's 2.33%, the overall negative trends in longer-term returns, such as a 1-year decline of -38.9% versus the S&P 500's 17.14%, highlight the volatility and risks associated with this stock. Given these factors, Shattuck Labs, Inc. is considered overvalued in the current market context.

Is Shattuck Labs, Inc. technically bullish or bearish?

As of September 10, 2025, Shattuck Labs, Inc. shows a neutral technical trend with mixed signals, outperforming the S&P 500 in the short term but underperforming over the past year.

As of 10 September 2025, the technical trend for Shattuck Labs, Inc. has changed from mildly bullish to sideways. The current stance is neutral, with mixed signals across various indicators. The MACD is bullish on the weekly chart but mildly bullish on the monthly, while the RSI indicates a bearish trend on the weekly and no signal on the monthly. The Bollinger Bands show a bullish signal weekly but a mildly bearish one monthly. Moving averages are mildly bearish on the daily timeframe. KST is bullish weekly but bearish monthly, and Dow Theory indicates a mildly bullish stance on both weekly and monthly charts. <BR><BR>In terms of performance, Shattuck Labs has significantly outperformed the S&P 500 over the past week and month, with returns of 12.63% and 118.63% respectively, but has underperformed over the longer term, with a 1-year return of -38.9% compared to the S&P 500's 17.14%.